We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radiosurgery System Targets Tumors Moving in Respiration

By HospiMedica staff writers
Posted on 02 Aug 2004
A new technology is capable of delivering dynamic radiosurgery to targets that move in respiration, such as liver, lung, kidney, and pancreatic tumors. More...


The Synchrony respiratory tracking system, developed by Accuray (Sunnyvale CA, USA), is a new enhancement to the CyberKnife stereotactic radiosurgery system, also manufactured by Accuray. The Synchrony system enables real-time dynamic tracking and delivery of a highly precise dose of radiation to targets that move with respiration.

"Launching the Synchrony system represents a major advance in the technology of radiation treatments. The human body is a dynamic, moving organism, but traditional radiation treatment devices have a static approach to treatment delivery that is unable to compensate for the body's natural motion. [This system] maximizes the benefits of the CyberKnife robotic, image-guided capability to track tumors as they move, and now opens a new cancer marker to radiosurgery,” said Euan Thomson, Ph.D., president and CEO of Accuray.

This system has been involved in treatment applications at the University of California, San Francisco (UCSF; CA, USA) for one year. "The Synchrony system represents true dynamic radiosurgery--the ability to irradiate targets accurately as they are moving. This is an extraordinary advance in extracranial radiosurgery because it allows physicians to use much tighter margins to treat tumors that move with breathing. More healthy tissue is spared because it is no longer necessary to use larger margins to compensate for movement of tumors. We have used [this system] over the last year at our institution with promising results,” remarked David Larson, M.D., Ph.D., professor of radiation oncology at UCSF Medical Center.




Related Links:
Accuray

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.